The Human Positive Cofactor 4 is a Promising Chemotherapeutic Target in Lung Adenocarcinoma

Figure 6

PC4 decreases lung adenocarcinoma cell sensitivity to DMOG and rapamycin. A-L PC4-knockdown or PC4-overexpression LUAD cells were treated with 1 µM A-485, 1 mM DMOG, 30 µM LY294002, 30 µM MG132, 10 µM MHY1485, or 30 nM rapamycin either alone or in combination with cisplatin. An individual cisplatin + DMSO control group was established for each drug.  < 0.05.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)